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BACKGROUND Data from remote monitoring (RM) of cardiovascular implantable electronic devices (CIEDs) currently are not accessible to patients despite demand. The typical RM report contains
multiple pages of data for trained technicians to read and interpret
and requires a patient-centered approach to be curated to meet individual user needs.
OBJECTIVE The purpose of this study was to understand which RM
data elements are important to patients and to gain design insights
for displaying meaningful data in a digital dashboard.
METHODS Adults with implantable cardioverter–deﬁbrillators
(ICDs) and pacemakers (PMs) participated in this 2-phase, usercentered design study. Phase 1 included a card-sorting activity to
prioritize device data elements. Phase 2 included one-on-one
design sessions to gather insights and feedback about a visual
display (labels and icons).
RESULTS Twenty-nine adults (mean age 71.8 6 11.6 years; 51.7%
female; 89.7% white) participated. Priority data elements for both
ICD and PM groups in phase 1 (n 5 19) were related to cardiac

Introduction
Cardiovascular implantable electronic devices (CIEDs) are
increasing in number and complexity and require timely
monitoring and patient follow-up for optimal care.1 Technical advances have enabled the use of remote monitoring
(RM) in lieu of in-ofﬁce interrogations to record and transmit
CIED data.2 RM increases clinical efﬁciency, lowers health
care costs, and improves patient safety, satisfaction, and

episodes, device activity, and impedance values. Recommended
replacement time for battery was high priority for the PM group
but not the ICD group. Phase 2 (n 5 10) revealed that patients
would like descriptive, nontechnical terms to depict the data and
icons that are intuitive and informative.
CONCLUSION This user-centered design study demonstrated that
patients with ICDs and PMs were able to prioritize speciﬁc data
from a comprehensive list of data elements that they had never
seen before. This work contributes to the goal of sharing RM data
with patients in a way that optimizes the RM feature of CIEDs for
improving patient outcomes and clinical care.
KEYWORDS Digital health; Health informatics; Implantable cardioverter–deﬁbrillator; Pacemaker; Remote monitoring
(Heart Rhythm O2 2020;1:136–146) © 2020 Heart Rhythm Society.
Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/).

clinical outcomes.3 Foundational in caring for patients with
complex cardiac disorders requiring CIED implant is
engaging the patient in shared decision-making, as recently
mandated by the Centers for Medicare and Medicaid Services
(CMS) for cardiovascular procedures.4 This work is part of a
larger effort to leverage RM data elements in a meaningful
way to move patients along a path of increasing engagement
and ultimately enhance decision-making for self-care.

This research is funded by Medtronic PLC. The content is solely the responsibility of the authors and does not necessarily represent the ofﬁcial views of
Medtronic PLC and Parkview Health. Dr Toscos has received research grants from Medtronic PLC, Biotronik, Agency for Healthcare Research and Quality
(AHRQ), Janssen Pharmaceuticals, and iRhythm Technologies, Inc.; and honoraria from Medtronic PLC. Dr Mirro has received grants from Biotronik, Inc,
Agency for Healthcare Research and Quality (AHRQ), Medtronic PLC, and Janssen Scientiﬁc Affairs; consulting fees/honoraria from iRhythm Technologies,
Inc., and Zoll Medical Corporation; and reports non-public equity/stock interest in Murj, Inc./Viscardia outside the submitted work. Dr Mirro’s relationships with
academia include serving as trustee of Indiana University. All other authors have reported that they have no conﬂicts relevant to the contents of this paper to
disclose. Address reprint requests and correspondence: Ms. Carly N. Daley, Parkview Mirro Center for Research and Innovation, 10622 Parkview Plaza
Dr, Fort Wayne, IN 46845. E-mail address: carly.daley@parkview.com.
2666-5018/© 2020 Heart Rhythm Society. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

https://doi.org/10.1016/j.hroo.2020.04.005

Daley et al

Involving Patients in CIED Data Dashboard Design

KEY FINDINGS
-

Adult patients with pacemakers and implantable
cardioverter–deﬁbrillators were able to prioritize
which data elements were important to them from a
comprehensive list of remote monitoring data elements, facilitated by a user-centered design process.

-

Preferences for the amount of data varied. High priority data selected by patients with either pacemakers or implantable cardioverter–deﬁbrillators
were cardiac episodes, device activity, and impedance values.

-

Simpliﬁed yet informative language (descriptive,
nontechnical terms) and intuitive icons are needed
to enhance presentation and communication about
the data.

Currently, there is little to no transparency of data collected
through RM for patients.5 Some applications allow patients to
see a limited amount of information, such as battery status and
when a transmission has occurred.6,7 Patients desire increased
access to their RM data,8–13 including patient advocates, who
have asserted their right to access the data generated by a
device implanted permanently inside their body.14 Patients
also report a general lack of knowledge about their device,15
so engagement in RM data may improve their understanding.
Furthermore, understanding patients’ information needs and
what they perceive as important may enhance patient–
clinician communication about RM, particularly for patients
who are concerned about replacing in-person visits with
RM.16,17 Importantly, access to health data may lead to improvements in value-based care and reduction of health care
costs by helping connect patients with their health care providers.18 In previous work, we examined the feasibility of
delivering a summary and full disclosure (all data in the
RM report) of implantable cardioverter–deﬁbrillator (ICD)
data to patients through a personal health record or portal.8,9
These studies revealed the need for greater understanding of
the design elements required to assist patients in using the
data. We then conducted focus groups and design-related
queries to understand how patients with heart failure would
want to receive alerts about left ventricular pacing from their
device.19,20 The ﬁndings from this entire body of work
conﬁrmed that many patients are interested in receiving RM
data (eg, battery status); however, the data in the RM report
should be simpliﬁed and tailored.8,9,19,21 The current study
expands on the previous user-centered design work by asking
patients to consider the utility of a comprehensive list of ICD
and pacemaker (PM) data elements in the very nascent stages
of the design of RM dashboards toward the goal of more fully
tailoring information to individual needs.
Understanding patient preferences for speciﬁc data is
increasingly important, as patients are faced with a growing
number of sources of health data.22 Understanding patient
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preferences also provides insight into tailoring clinically relevant data to patients’ needs and expectations.23–25 Thus, we
used a user-centered approach with people who have ICDs
and PMs to generate rich insights regarding patients’ preferences for receiving RM data that can be translated into design.
User-centered design actively engages end-users and
stakeholders throughout the entire design process.26 A variety of scientiﬁc methods (eg, questionnaires, interviews,
and focus groups), along with generative design activities,
are typically conducted in multiple sessions with a small
group of 6–20 participants27 to identify user needs, explore
meaningful communication (content and presentation), and
validate ideas in realistic use case scenarios. Through usercentered design research, patterns may emerge on how to
create solutions that work for a larger population.
The present study engaged patients in 2 design phases. In
the ﬁrst phase, patients participated in an educational session
and discussion about RM data with experts and other patients. They received a comprehensive list of RM data elements from Medtronic (Medtronic PLC, Minneapolis, MN)
RM reports (37 discrete data elements for dual-chamber
PMs and 55 discrete data elements for dual-chamber ICDs)
from which to select the data they would want included in
an online dashboard. In the second phase, patients’ preferences for the presentation (icon and label) of data elements
were explored. Building on our previous report of ﬁndings,28
the primary aims of this design study were to (1) identify
which RM data elements are of high priority to patients
with PMs and ICDs; (2) identify which supplemental information can help with interpreting the data and how frequently
patients would like to receive the data; and (3) gather patients’ feedback on a visual display of the highest prioritized
data elements, including icons, data labels, and descriptions.
The ﬁndings from this study contributed to initial recommendations for designing digital dashboards of CIED data for
patients with ICDs and PMs. The ﬁndings can help clinicians
understand areas of support that patients need to comprehend
RM data and their device functionality. This work is foundational in order to engage patients in a meaningful way,
improve their understanding of the functionality of their
CIED through the use of digital health technology, and
further enhance their personal understanding and selfmanagement of underlying cardiac disease.

Methods
Design
This exploratory, user-centered design study used a mixedmethods approach involving surveys, card-sorting sessions
(phase 1), and one-on-one design sessions with a second
set of participants (phase 2). All participants provided
informed consent and were given a $40 debit card incentive
payment. Both phases were recorded on video (with audio),
and researchers took observation notes. The study was
approved by the institutional review board (Parkview
Health).
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Figure 1

Example of card used during card-sorting activity.

Setting and sample
The study was conducted at a large, not-for-proﬁt health system in the Midwestern United States that serves .5000 patients with CIEDs. Adult (age .18 years) outpatient
cardiology patients were recruited via telephone if they had
a Medtronic dual-chamber ICD or dual-chamber PM, had
been enrolled in CareLink (Medtronic PLC) RM for 6
months, and were approved by the principal investigator
for contact. Patients who met these criteria (approximately
155) were contacted in alphabetical order to recruit for the
sessions until 10 ICD and 10 PM participants were scheduled
for phase 1, and 5 ICD and 5 PM patients were scheduled for
phase 2, with no overlap between phases. Dual-chamber
ICDs and PMs, speciﬁcally, were included to harmonize
the dataset provided. Informal caregivers were invited to
join patient participants for phase 1; however, the cardsorting task was completed solely by the patient participants.

Surveys
After the consent process and at the start of the sessions, all
participants were surveyed using 3 validated instruments:
(1) the Newest Vital Sign (NVS),29 a 6-question health literacy survey; (2) the Multidimensional Health Locus of Control (MHLC) scale, Form C,30 a 24-item scale to assess a
person’s beliefs regarding who or what has control over their
health and wellbeing; and (3) the Altarum Consumer Engagement (ACE) Measure,31 a 12-item scale to measure patient
engagement across 3 subscales: Commitment, Informed
Choice, and Navigation. Commitment refers to capability
to manage one’s own health, Informed Choice is the extent
to which a person looks for and uses health-related

information, and Navigation refers to expertise at using the
health system.

Phase 1 procedure
Phase 1 involved 4 group sessions with a total of 10 participants with PMs and 9 with ICDs. The ﬁrst and second sessions included 4 and 6 participants with PMs, respectively.
The third and fourth sessions included 3 and 6 participants
with ICDs, respectively. Each session lasted up to 3 hours,
starting with the consent process and including team introductions and breaks during the sessions.
Educational introduction (10 minutes)
Each session began with an educational video explaining
how the device (PM or ICD) works to treat a diagnosed condition, the purpose of RM, and how health care providers
interpret RM data. The video was created by 2 study team
members, a research registered nurse (RN) with 10 years of
electrophysiology experience (S.W.), and a cardiologist
specializing in electrophysiology with 30 years of clinical
experience (M.M.).
Card-sorting activity (45 minutes)
Participants were given a stack of paper cards containing
discrete data elements (37 PM; 55 ICD) from Medtronic
RM reports, grouped under categories assigned by the
research RN (Supplemental Appendix A). Each card
included the data category (eg, Device Activity), label, value,
and description of what the value meant in the context of
CIED operation (Figure 1). Each participant individually
sorted the cards as “High Priority,” “Low Priority,” or
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Figure 2 Example cards used in individual design sessions. A: Front and back of the “Total Ventricular Pacing (VP)” card with the “simple” label option. The
other 2 alternatives were “original”: Total Ventricular Pacing (VP) and “descriptive”: Percentage of Time Device Pacing Ventricle. B: Possible icons and labels
for the “Treated AT/AF Episodes” card. AF 5 atrial ﬁbrillation; AT 5 atrial tachycardia; RM 5 remote monitoring.

“Discard.” Only 5 cards could be selected as high priority.
For high- and low-priority selections, participants were
prompted to select from a list on the back of the cards (generated by the research team) of desired supporting information
and frequency of data delivery.
Discussion (45 minutes)
Researchers facilitated the discussion among participants
regarding rationale for data prioritization. Discussions in
this phase also provided an opportunity for participants to
learn more about the data from each other and make changes
to their original selections if desired.
Dashboard card development
After completion of phase 1, researchers calculated the 9
highest-priority data elements by applying the following formula to each element: [(number of participants who selected
high priority ! 2) 1 (number of participants who selected
low priority ! 1)]/(total number of participants ! 2), producing scores of 0–1. High-priority selections were weighted
twice as much as low-priority selections. Using this formula,
if all participants chose a data element as high priority, that
data element would have the highest possible score (1.0).
Once the 9 highest-priority data elements were determined,
researchers developed cards that included 3 label options

(original from RM report, simpliﬁed, and descriptive) and 2
icon options, for a total of 6 alternative representations
(Figure 2).

Phase 2 procedure
Phase 2 involved 10 one-on-one design sessions, lasting
approximately 90 minutes each. Five participants had PMs,
and 5 had ICDs. Participants in phase 2 did not participate
in phase 1.
Dashboard building activity
Participants were given 9 stacks of 7 cards (the 6 alternative
representations of each high-priority phase 1 data element,
plus a blank card for additional suggestions). They interpreted each data element based on the front side before
reading the explanation on the back, then placed the card
they felt was the best representation out of the 6 alternatives
on top of each stack. Participants were also asked to rate (on a
5-point scale) the overall ease of understanding and usefulness of the 9 cards they selected.

Data analysis
Descriptive statistics (frequency) were calculated for survey
items using Excel 2016. Qualitative data were gathered
from ﬁeld notes and video recordings from both phases.
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Table 1

Participant characteristics

Participant characteristics
Device type
Dual-chamber PM
Dual-chamber ICD
Age (y)
.76
66–75
56–65
46–55
36–45
26–35
Gender
Female
Male
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Decline to answer
Race
White
Black or African American
Other
American Indian, Alaska Native
Native Hawaiian, Paciﬁc Islander
Asian
Education
Trade/some college
College graduate
High school/GED
Postgraduate
Did not complete high school
Current employment status
Retired
Disabled/unable to work
Employed part-time
Employed full-time
Unemployed

Phase 1 (N 5 19)

Phase 2 (N 5 10)

Total (N 5 29)

10 (52.6)
9 (47.3)

5 (50.0)
5 (50.0)

15 (51.7)
14 (48.2)

7 (36.8)
5 (26.3)
6 (31.6)
0 (0.0)
1 (5.3)
0 (0.0)

3 (30.0)
6 (60.0)
0 (0.0)
0 (0.0)
1 (10.0)
0 (0.0)

10 (34.5)
11 (37.9)
6 (20.7)
0 (0.0)
2 (6.9)
0 (0.0)

10 (52.6)
9 (47.4)

5 (50.0)
5 (50.0)

15 (51.7)
14 (48.3)

0 (0.0)
17 (89.4)
2 (10.5)

0 (0.0)
10 (100)
0 (0.0)

0 (0.0)
27 (93.1)
2 (6.8)

17 (89.5)
1 (5.3)
1 (5.3)
0 (0.0)
0 (0.0)
0 (0.0)

9 (90.0)
1 (10.0)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)

26 (89.7)
2 (6.9)
1 (3.4)
0 (0.0)
0 (0.0)
0 (0.0)

7 (36.8)
6 (31.6)
5 (26.3)
1 (5.3)
0 (0.0)

4 (40.0)
3 (30.0)
0 (0.0)
3 (30.0)
0 (0.0)

11 (37.9)
9 (31.0)
5 (17.2)
4 (13.8)
0 (0.0)

14 (73.7)
4 (21.1)
0 (0.0)
1 (5.3)
0 (0.0)

7 (70.0)
1 (10.0)
2 (20.0)
0 (0.0)
0 (0.0)

21 (72.4)
5 (17.2)
2 (6.9)
1 (3.4)
0 (0.0)

Values are given as n (%).
GED 5 General Educational Development test; ICD 5 implantable cardioverter–deﬁbrillator; PM 5 pacemaker.

Results
Participant characteristics
Participants in this study were mostly older than 65 years
(mean 71.8 6 11.6 years), white (89.7%), and retired
(72.4%); gender distribution was fairly equal (51.7% female,
48.3% male) (Table 1).

Survey results
Participants demonstrated adequate health literacy on the
NVS survey (79.3%) and high health engagement on the
ACE measure (96.6% of participants scored high for
Commitment and Navigation, and 62.1% scored high for
Informed Choice). Participant scores on the MHLC measure
were high for doctor locus of control, internal, and others;
scores were low for chance (Table 2).

Prioritization of device data elements
During phase 1, 865 total cards were sorted. Three of the
highest-priority data elements for both ICD and PM groups
were related to the Cardiac episodes category. Whereas

recommended replacement time was high priority for the
PM group, none of the battery-related data elements were
highest priority for the ICD group (Table 3).
Observation notes captured during the discussion revealed
reasons for discarding data, including perceived irrelevance
to their health condition, too much information, numbers being less useful than the interpretation, and lack of understanding. One participant stated, “I would rather go into the ofﬁce
and speak to the cardiologist one-on-one.”

Desired supporting information and frequency of
receiving data
Among the 428 total cards selected as high or low priority,
there were 563 selections for supporting information (participants could select more than one or none of the options).
“The normal/safe range” was selected most (31.6%) along
with “Whether or not my doctor has reviewed this information” (31.0%), followed by “Actions I can take if the value
is outside the normal range” (26.3%) and “A more detailed
explanation” (11.1%). “Other” was not selected. A total of
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Aggregated survey results for each phase
Phase 1 (N 5 19)

NVS
Adequate literacy
High likelihood of limited literacy
Possibility of limited literacy
ACE
Informed choice
Low
Medium
High
Commitment
Low
Medium
High
Navigation
Low
Medium
High
MHLC
Internal
High
Low
Chance
High
Low
Doctors
High
Low
Others
High
Low

Phase 2 (N 5 10)

Total (N 5 29)

14 (73.7)
2 (10.5)
3 (15.8)

9 (90.0)
1 (10.0)
0 (0.0)

23 (79.3)
3 (10.3)
3 (10.3)

0 (0.0)
6 (31.6)
13 (68.4)

0 (0.0)
5 (50.0)
5 (50.0)

0 (0.0)
11 (37.9)
18 (62.1)

0 (0.0)
0 (0.0)
19 (100.0)

1 (10.0)
0 (0.0)
9 (90.0)

1 (3.4)
0 (0.0)
28 (96.6)

0 (0.0)
1 (5.3)
18 (94.7)

0 (0.0)
0 (0.0)
10 (10.0)

0 (0.0)
1 (3.4)
28 (96.6)

16 (84.2)
3 (15.8)

8 (80.0)
2 (20.0)

24 (82.8)
5 (17.2)

6 (31.6)
13 (68.4)

1 (10.0)
9 (90.0)

7 (24.1)
22 (75.9)

19 (100.0)
0 (0.0)

10 (100.0)
0 (0.0)

29 (100.0)
0 (0.0)

12 (63.2)
7 (36.8)

9 (90.0)
1 (10.0)

21 (72.4)
8 (27.6)

Values are given as n (%).
ACE 5 Altarum Consumer Engagement; MHLC 5 Multidimensional Health Locus of Control; NVS 5 Newest Vital Sign.

391 selections were made for frequency. “Every 3 months”
was selected most (56.3%), followed by “Every month”
(18.2%) and “Once a year” (12.5%). Notably, “Every day”
was never selected.

Feedback about the display and receiving data
In phase 2, participants rated the ease of understanding at
3.15 of 5 and usefulness at 4.4 of 5 for the overall visual representations and offered speciﬁc feedback and insights for
improvement.

looking at street signs that we all know.” Suggestions
included an icon with a device connecting to the heart
indicating which part of the heart was being paced by
the wire, a heart with a lightning bolt symbol for treated
atrial tachycardia/atrial ﬁbrillation episodes, and a “happy
heart” symbol when there were no episodes.

Amount of data: Participants ranged from not wanting information at all or only directly from their doctor, to
wanting details such as dates and times of episodes.
This was consistent with phase 1, in which some participants expressed the idea that “what I don’t know doesn’t
hurt me,” whereas others were enthusiastic about the possibility of receiving all possible “hidden” data.

Labels: Of the 3 label options provided (simpliﬁed,
descriptive, or as it appears on the standard RM report),
most participants (51.7%) chose the descriptive labels.
Generally, participants felt the language on the standard
RM report was “too technical.” One person stated, “I am
an educated man and still had a lot of difﬁculty with understanding the cards. Simplify it.” Participants (ICD)
suggested using “canceled” instead of “aborted,” and
“wire” instead of “lead.” Two participants suggested using “wire condition” to replace “lead impedance.”

Discussion

Icons: Although participants understood the icons overall,
several misinterpreted or had trouble integrating pictures
with explanations. One person noted, “It’s not like we’re

Because device data are ubiquitous, clinicians may soon be
called upon to provide support for ICD and PM patients
who engage in self-monitoring and interpretation of their device data. To that end, we used user-centered design principles to engage patients in feedback for a digital dashboard

PM and ICD dashboards created after phase 2 ﬁndings
show the aggregated top choices for labels and icons representing the 9 highest-priority data elements (Figure 3).
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Table 3
and PMs

Card prioritization by category and preference score for high-priority data elements within each category, for participants with ICDs

Data category
Battery life

Total
Device (n) Cards selections HP (%)

LP (%)

D (%)

ICD (9)
PM (10)
Total
ICD (9)

5
5
10
7

45
50
95
63

6 (13.3) 12 (26.7)
20 (40.0) 7 (14.0)
26 (27.4) 19 (20.0)
10 (15.9) 26 (41.3)

PM (10)

2

20

12 (60.0)

5 (25.0)

3 (15.0)

Total
Device information ICD (9)

9
8

83
72

22 (26.5) 31 (37.3)
16 (22.2) 16 (22.2)

30 (36.1)
40 (55.6)

PM (10)
Total
Device settings
ICD (9)
PM (10)
Total
Health information ICD (9)
PM (10)

6
14
15
13
28
5
6

60
132
135
130
265
45
60

13 (21.7)
29 (22.0)
4 (3.0)
21 (16.2)
25 (9.4)
5 (11.1)
18 (30.0)

Total
ICD (9)

11
15

105
135

23 (21.9) 37 (35.2)
18 (13.3) 54 (40.0)

45 (42.9)
63 (46.7)

PM (10)

5

50

21 (42.0) 18 (36.0)

11 (22.0)

Total

5

185

39 (21.1) 72 (38.9)

74 (40.0)

Device activity

Cardiac episodes

27 (60.0)
23 (46.0)
50 (52.6)
27 (42.9)

20 (33.3) 27 (45.0)
36 (27.3) 67 (50.8)
26 (19.3) 105 (77.8)
43 (33.1) 66 (50.8)
69 (26.0) 171 (64.5)
12 (26.7) 28 (62.2)
25 (41.7) 17 (28.3)

Highest-priority data elements
(9 from each group; 18 total)

Preference
score

None
RRT
—
Aborted charges AT/AF
Total ventricular pacing (VP)
Atrial sensing (AS)
Atrial pacing (AP)
—
RV deﬁbrillation impedance
SVC deﬁbrillation impedance
Atrial pacing impedance
RV pacing impedance
Atrial pacing impedance
—
None
None
—
None
Observations
Average ventricular rate during AT/AF
—
Monitored AT/AF episodes
Treated AT/AF episodes
Pace-terminated VT/VF episodes
Monitored AT/AF episodes
Pace-terminated AT/AF episodes
Treated AT/AF episodes
—

N/A
0.60
—
0.50
0.50
0.85
0.60
—
0.61
0.61
0.56
0.56
0.75
—
N/A
N/A
—
N/A
0.65
0.65
—
0.67
0.50
0.50
0.75
0.70
0.60
—

AF 5 atrial ﬁbrillation; AT 5 atrial tachycardia; D 5 discard; HP 5 high priority; ICD 5 implantable cardioverter–deﬁbrillator; LP 5 low priority; N/A 5 not
applicable; PM 5 pacemaker; RRT 5 recommended replacement time; RV 5 right ventricle; SVC 5 superior vena cava.

(which would be accessible to both clinicians and patients)
for ICD and PM data.
Importantly, participants with PMs and ICDs were able
to prioritize preferred data elements from a comprehensive
list of RM data. Battery status (recommended replacement
time) was highly prioritized among PM participants but
not ICD participants, which may be due to the indication
of signiﬁcant bradyarrhythmia (sinus node dysfunction or
atrioventricular block) and effect of intermittent pacing on
the battery. In previous research, patients with CIEDs expressed a desire for battery status information.15,19,21 However, participants with ICDs who received their device for
primary prevention of sudden cardiac death may ﬁnd ventricular events and therapies, and the integrity of the leads
involved, to be of the highest priority rather than the battery. The education session prior to the card-sorting prioritization task may have inﬂuenced participant choices.
Table 4 summarizes the ﬁndings from this study that
contribute to design recommendations and related implications for patient care.

Future studies
As data from RM become available to patients with all types
of CIEDs, efforts to design personalized dashboards for
various devices and conditions should build on the current

ﬁndings to provide meaningful impact. These designs can
be tested in a larger pilot study to validate patient needs
across populations. Furthermore, personalized dashboards
of RM data should be evaluated for their ability to optimize
remote data monitoring and enhance communication about
the device between patients and clinicians. There is also a
need to explore clinicians’ preferences and needs for data presentation to facilitate communication through a shared interface.

Study limitations
The study sample was small and predominantly white, which
is representative of the population of patients with Medtronic
ICDs or PMs in the health system where recruitment took
place. No stratiﬁcation during recruitment was used to increase the diversity of the study sample. Participants were
mostly retired, with adequate health literacy and high engagement in their care. Thus, the ﬁndings of this study are not
generalizable to all patients with ICDs and PMs due to the
size and uniformity of the sample. Future research should
include a more diverse sample to more thoroughly examine
user needs and reduce disparities.38 Reasons for implant
and experience with the device (eg, shocks, generator
changes, etc) could impact patients’ preferences for RM
data and should be examined in future work. Although this
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Figure 3 Pacemaker and implantable cardioverter–deﬁbrillator (ICD) dashboards created from phase 2 ﬁndings. AF 5 atrial ﬁbrillation; AT 5 atrial tachycardia; RRT 5 recommended replacement time; RV5 right ventricle; VF 5 ventricular ﬁbrillation; VT 5 ventricular tachycardia.

study provided a descriptive assessment of patient preferences, standard measurements to evaluate interpretation and
emotive responses to data and displays would provide additional insight to support design decisions.

Clinical implications
This work provides a foundational step in investigating how
to engage CIED patients with their device data. For example,
patients with cardiac resynchronization therapy PM and
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Table 4

Design recommendations and implications of the ﬁndings for sharing RM data with patients

Study ﬁnding
Preference

Design recommendation

Implication

 Amount of data

 None to as much as possible.

 Integrate a ﬂexible display to allow
minimal to high detail of information.

 Supporting information

 Include reference ranges, instructions
on what to do, and notiﬁcation that
the clinician is seeing the data.
 Talking to a clinician may be preferred
over digital data alone.

 Provide supplemental information
that supports self-care without losing
clinician guidance and expertise.

 Language

 Simplify overall and change certain
words (eg, “aborted” to “canceled”).

 Use language that is familiar and
preferable while still clinically
accurate.

 Frequency

 Most chose “every 3 months,” which
may reﬂect their current RM frequency
of scheduled transmissions.

 Designs should be adaptable, as
patients’ needs may change with new
experiences.

 Understanding how much RM data to
share with individuals may be
optimized using a shared decisionmaking process32 to explore
preferences and needs.
 Supporting information in the
dashboard should aim toward
establishing connection between
patient and clinician, an aspect of inperson visits that is important to
some patients.17,33
 Efforts to standardize terminology
across device vendors34 should also
consider establishing plain, clear, and
familiar language for labeling data in
patient-facing interfaces,35,36 as this
may enhance understandability and
interpretability for clinicians outside
of electrophysiology.
 Over time, as patients gain experience
with monitoring their data and/or
changes in health, preferences may
change37 and may need to be reevaluated.

RM 5 remote monitoring.
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Design category
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deﬁbrillator devices undergoing treatment for heart failure
with reduced ejection fraction have a complex self-care
regimen. This cohort could beneﬁt from engaging in their
CIED data as part of a holistic care plan that includes optimization of guideline-directed medical therapy and lifestyle
modiﬁcations (eg, diet and activity). Our future work will
focus on subpopulations of CIED patients with speciﬁc
care needs and measure the impact of patient engagement
on medication adherence as well as economic and clinical
outcomes. The clinical implications of leveraging CIED
RM data would be transformational in caring for patients
with advanced cardiac disease.

Conclusion
This study demonstrates that patients with PMs and ICDs
were able to prioritize which data were important to them
when provided with a list of RM data elements. This usercentered design method demonstrates a valuable approach
for developing informative yet simple displays to facilitate
understanding and promote self-care. Engaging patients
with their data through a meaningful display could help facilitate decision-making between patients and their clinician
and optimize the RM aspect of patient care.
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